Ultivue Subspecialties Oncology

Adjuvant COX Inhibition Augments Cytolytic T Cell Infiltration in Irradiated Triple Negative Breast Tumors

Immune therapy has emerged as the new frontier of cancer treatment.

02/21/2022 11:00 EST

February 21, 2023 - 11:00 EST

Immune therapy has emerged as the new frontier of cancer treatment. Therapeutic radiation is a known inducer of an immune response that can be limited by immunosuppressive mediators including cyclooxygenase-2 (COX2), which is highly expressed in triple negative breast tumors.

Diagnostics Infectious Disease Omics Biochemistry and molecular biology

March 23, 2023

Using Single-Cell Sequencing to Investigate Murine COVID-19 Mortality

Subspecialties Oncology

December 1, 2022

Understanding the immune landscape of non-muscle invasive bladder cancer (NMIBC) and its influence on BCG immunotherapy

Diagnostics Omics

December 2, 2022

Adjuvant COX Inhibition Augments Cytolytic T Cell Infiltration in Irradiated Triple Negative Breast Tumors

More Webinars

Using Single-Cell Sequencing to Investigate Murine COVID-19 Mortality

Understanding the immune landscape of non-muscle invasive bladder cancer (NMIBC) and its influence on BCG immunotherapy

Unlocking Precision Oncology with Genomics - ESMO Roundtable

Recommended

Explore

Featured Topics

Issues

Career Development

Educational Resources

Events

People & Profiles

Adjuvant COX Inhibition Augments Cytolytic T Cell Infiltration in Irradiated Triple Negative Breast Tumors

Newsletters

More Webinars

Using Single-Cell Sequencing to Investigate Murine COVID-19 Mortality

Understanding the immune landscape of non-muscle invasive bladder cancer (NMIBC) and its influence on BCG immunotherapy

Unlocking Precision Oncology with Genomics - ESMO Roundtable

Recommended